Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment

Science

Volumn 353, Issue 6305, 2016, Pages 1237-1240

  Lomonossoff, George P ^a   D'Aoust, Marc André ^b  

^a JOHN INNES CENTRE   (United Kingdom)

^b Usine des Molecules Recombinantes   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT PROTEIN; BIOLOGICAL PRODUCT; DRUG; RECOMBINANT PROTEIN; VACCINE;

BIOREACTOR; BIOTECHNOLOGY; COMMERCIALIZATION; DRUG; LITERATURE REVIEW; PLANT; PROTEIN;

BIOREACTOR; CLINICAL RESEARCH; DRUG MANUFACTURE; DRUG RESEARCH; PHARMACEUTICS; PLANT; PRIORITY JOURNAL; REVIEW; BIOSYNTHESIS; GENE TRANSFER; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN SYNTHESIS; TRANSGENIC PLANT;

BIOLOGICAL PRODUCTS; BIOREACTORS; GENE TRANSFER TECHNIQUES; PHARMACEUTICAL PREPARATIONS; PLANTS, GENETICALLY MODIFIED; PROTEIN BIOSYNTHESIS; RECOMBINANT PROTEINS; VACCINES;

EID: 84988422001     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf6638     Document Type: Review

References (40)

1. European Medicines Agency, "Guidelines on the quality of biologically active substances produced by stable transgene expression in higher plants," www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003154.pdf.
2. A. Hiatt, R. Cafferkey, K. Bowdish, Nature 342, 76-78 (1989).
3. H. S. Mason, D. M. Lam, C. J. Arntzen, Proc. Natl. Acad. Sci. U.S.A. 89, 11745-11749 (1992).
4. J. K. Ma et al., Science 268, 716-719 (1995).
5. T. A. Haq, H. S. Mason, J. D. Clements, C. J. Arntzen, Science 268, 714-716 (1995).
6. E. P. Rybicki, Virol. J. 11, 205 (2014).
7. P. Saxena, G. P. Lomonossoff, in Viral Nanotechnology, Y. Khudyakov, P. Pumpens, Eds. (CRC Press, 2016), pp. 251-262.
8. Y. Y. Gleba, D. Tusé, A. Giritch, Curr. Top. Microbiol. Immunol. 375, 155-192 (2014).
9. H. Peyret, G. P. Lomonossoff, Plant Biotechnol. J. 13, 1121-1135 (2015).
10. M. M. Goodin, D. Zaitlin, R. A. Naidu, S. A. Lommel, Mol. Plant Microbe Interact. 21, 1015-1026 (2008).
11. Y. Tekoah et al., Plant Biotechnol. J. 13, 1199-1208 (2015).
12. T. Rademacher, "Method for the generation and cultivation of a plant cell pack," patent WO 2013113504 (2013).
13. K. J. Whaley et al., Curr. Top. Microbiol. Immunol. 375, 107-126 (2014).
14. A. Loos et al., Proc. Natl. Acad. Sci. U.S.A. 111, 6263-6268 (2014).
15. J. Zischewski, M. Sack, R. Fischer, Biotechnol. J. 11, 107-116 (2016).
16. J. Marsian, G. P. Lomonossoff, Curr. Opin. Biotechnol. 37, 201-206 (2016).
17. H. Peyret et al., PLOS ONE 10, e0120751 (2015).
18. Y. Shaaltiel et al., Plant Biotechnol. J. 5, 579-590 (2007).
19. J. S. Shen et al., J. Inherit. Metab. Dis. 39, 293-303 (2016).
20. J. L. Fox, Nat. Biotechnol. 30, 472 (2012).
21. C. O. Tacket et al., Nat. Med. 4, 607-609 (1998).
22. P. Juarez, V. Virdi, A. Depicker, D. Orzaez, Plant Biotechnol. J. 14, 1791-1799 (2016).
23. A. A. McCormick et al., Proc. Natl. Acad. Sci. U.S.A. 105, 10131-10136 (2008).
24. G. A. Grabowski, M. Golembo, Y. Shaaltiel, Mol. Genet. Metab. 112, 1-8 (2014).
25. A. Zimran et al., Blood 118, 5767-5773 (2011).
26. N. Landry et al., PLOS ONE 5, e15559 (2010).
27. N. Landry et al., Clin. Immunol. 154, 164-177 (2014).
28. S. Pillet et al., Clin. Immunol. 168, 72-87 (2016).
29. B. J. Ward et al., Vaccine 32, 6098-6106 (2014).
30. ClinicalTrials.gov-seasonal phase 2, "Immunogenicity of a quadrivalent virus-like particles (VLP) influenza vaccine in healthy adults," https://clinicaltrials.gov/ct2/show/NCT02768805?term=medicago&rank=2.
31. D. Tusé et al., BioMed Res. Int. 2015, 648143 (2015).
32. V. Yusibov, N. Kushnir, S. J. Streatfield, Annu. Rev. Plant Biol. 67, 669-701 (2016).
33. J. A. Weintraub et al., Caries Res. 39, 241-250 (2005).
34. J. V. Gavilondo, J. W. Larrick, Biotechniques 29, 128-132 (2000).
35. J. K. Ma et al., Plant Biotechnol. J. 13, 1106-1120 (2015).
36. R. Strasser et al., Plant Biotechnol. J. 6, 392-402 (2008).
37. X. Qiu et al., Nature 514, 47-53 (2014).
38. L. Zeitlin et al., Proc. Natl. Acad. Sci. U.S.A. 108, 20690-20694 (2011).
39. G. G. Olinger Jr. et al., Proc. Natl. Acad. Sci. U.S.A. 109, 18030-18035 (2012).
40. L. Bortesi, R. Fischer, Biotechnol. Adv. 33, 41-52 (2015).